Prior Therapy

CAM211 Study Design

• Must have received alkylating agent and failed fludarabine therapy

  • Failure to achieve CR or PR to at least one fludarabine regimen
  • Relapse within 6 months of last fludarabine dose

• 2-5 previous therapy regimens

Previous slide

Next slide

Back to first slide

View graphic version